BioNeutral Demonstrates Its Ogiene(TM) Multi-Purpose Cleaner Far Outperforms Leading European Products

NEWARK, N.J., Oct. 6, 2010 (GLOBE NEWSWIRE) -- BioNeutral Group, Inc. (OTCBB:BONU), a specialty chemical, technology-based life science company, has completed comparative testing of its Multipurpose Cleaner vs. leading branded European products. The tests demonstrate that Ogiene far outperforms leading competitive European products.

For the elimination of difficult to remove stains and various dirt and greasy grime, BioNeutral's Multipurpose Cleaner outperformed Terra Activ All-Purpose Cleaner and Green Works™ Natural All Purpose Cleaner. These two products represent new cleaners in Europe which use sustainable ingredients. However, these two products were ineffective compared to BioNeutral's environmentally friendly Multipurpose Cleaner when it came to removing really difficult stains and dirt. In addition to superior cleaning benefits, BioNeutral's water-based multipurpose cleaner also has the following positive environmentally friendly features: contains no polluting phosphates, chlorine, phenolics or endocrine mimickers and is nonabrasive. BioNeutral's Multipurpose Cleaner uses no ingredients which compete or detract from the world's food supply.

The following table provides representative stain removing results for BioNeutral's Multi-Purpose Cleaner vs. Green Works™ and Terra Activ cleaners:

(Stain removal results from Swift Lock Plus 30 Laminate Flooring.)

Dr. Andrew Kielbania, Chief Scientist of BioNeutral Group, Inc. said, "We are elated with the superior cleaning performance of our multipurpose cleaner compared to the European brands. Our environmentally friendly multipurpose cleaner contains no ingredients which detract from the world's food supply. This is in direct contrast with many of the newer 'sustainable' cleaners that use ingredients derived directly from grain, corn or beets. We believe no one should utilize sources of real food to make anything, much less cleaners, when there is a huge ongoing global need to feed the world's population."  

The Ogiene line of products is available in Europe, and has been approved for sale, and will soon be available, in the United States.

About BioNeutral Group, Inc.

Headquartered at the New Jersey Institute of Technology/EDC in Newark, BioNeutral Group, Inc., is a technology-based life science company which has developed a technology platform that neutralizes harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. BioNeutral's products, Ygiene and Ogiene, kill germs and clean surfaces with a dramatic increase in speed and power over their rivals in the marketplace. BioNeutral's proprietary platform technology has been proven effective in surface, water and airborne applications. Its antimicrobial line of products under the Ygiene™ brand have been submitted to the EPA for approval for sale in the United States and has already been approved for sale in Germany and is permitted to be sold in the UK, France and Sweden. For more information, see www.bioneutralgroup.com.

Forward-Looking Statements:

This release contains certain "forward-looking statements" relating to the business of the Company and its subsidiary companies. These forward looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions. Such forward looking statements involve known and unknown risks and uncertainties that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those described in the Company's filings with the Securities and Exchange Commission. BioNeutral routinely tests its formulations against those of its competitors. The results are published to let shareholders know how the Company's technology compares with known formulations in the market place. Any product claim for antimicrobial activity requires approval from the EPA or FDA, depending upon where and how the formulations are used. The EPA and FDA have not reviewed or confirmed the Company's data and findings. BioNeutral's antimicrobial formulations will be marketed under the brand name Ygiene™ and are not yet available for sale in the United States.